When designing stability protocols, formulation, storage, and dosing conditions must be assessed.
Melissa Whitsel
Advertisement
Articles by Melissa Whitsel
Pharmaceutical Technology Europe
A number of factors need to be considered when evaluating preclinical dose-formulation stability. The authors discuss formulation, storage and dosing conditions.
Advertisement
Latest Updated Articles
Preclinical Dose-Formulation StabilityJune 2nd 2012
Preclinical Dose-Formulation StabilityJune 1st 2012
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
5